ADVERTISEMENT
ADVERTISEMENT

TRASTORNOS DE LA FERTILIDAD EN LA MUJER CON DIABETES TIPO 1 Y 2

Laura Pomares, Carolina Gómez Martín, Natalia Maccio, Marisa Geller, Celina Bertona, Julia Migueles, Bárbara Arinovich, Ana Schindler, Natalia Garrido, Soraya Larreburo, Mónica Blanco, Santiago De Loredo, Lázaro González

Resumen


La fertilidad es la capacidad fisiológica de una mujer, de un hombre o de una pareja para producir un hijo vivo. Son múltiples los factores que pueden interferir en este complejo proceso. La diabetes mellitus -como enfermedad crónica que afecta el metabolismo- puede alterar dicho proceso en sus distintas etapas. En la siguiente revisión analizamos las evidencias existentes acerca de los distintos aspectos que relacionan la diabetes con las alteraciones de la fertilidad femenina.


Palabras clave


diabetes; mujer; fertilidad

Texto completo:

PDF

Referencias


Vargas R, Repke J, Ural S. Type 1 diabetes mellitus and pregnancy. Rev. Obstet. Gynecol. Summer; 3(3): 92-100, 2010.

Jonasson J, Brismar K, Sparén P, Lambe M, Nyrén O, Ostenson C, Ye W. Fertility in women with type 1 diabetes. A population-based cohort study in Sweden. Diabetes Care 30:2271-2276, 2007.

Conn J, Jacobs H, Conway G. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clinical Endocrinology. Vol 52. Issue 1. 81-86, 2000.

Solomon C. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286(19):2421-2426, 2001.

Shim U, Oh JY, Lee HJ, Hong YS, Sung YA. Long menstrual cycle is associated with type 2 diabetes mellitus in korean women. Diabetes Metab. J 35:384-389, 2011.

Codner E, Merino P, Tena-Sempere M. Female reproduction and type 1 diabetes: from mechanisms to clinical findings. Human Reproduction Update, Vol.18, Nº 5 pp. 568-585, 2012.

Arrais RF, Dib SA. The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review. Human reproduction. Vol 21. Nº 2: 327-337, 2006.

The diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. The N. Eng. J Med., 329: 977-986, 2003.

Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125, 2000.

La Marca A, Morgante G, De Leo V. Evaluation of hypothalamic-pituitary-adrenal axis in amenorrhoeic women with insulin-dependent diabetes. Hum. Reprod. 14:298-302, 1999.

Pal L, Chu HP, Shu J, Topalli I, Santoro N, Karkanias G. In vitro evidence of glucose-induced toxicity in GnRH secreting neurons: high glucose concentrations influence GnRH secretion, impair cell viability, and induce apoptosis in the GT1-1 neuronal cell line. Fertil Steril 88:1143-1149,2007.

Codner E, Cassorla F. Puberty and ovarian function in girls with type 1 diabetes mellitus. Horm. Res. 71:12-21, 2009.

Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC: The insulin-related ovarian regulatory system in health and disease. Endocr. Rev. 20: 535-582, 1999.

Hsueh AJ, Billig H, Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr. Rev. 15: 707-724, 1994.

Codner E, Soto N, López P, Trejo L, Avila A, Eyzaguirre FC, Iniguez G, Cassorla F: Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 91: 2250-2256, 2006.

Chang AS, Dale AN, Moley KH. Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology 146: 2445-2453, 2005.

Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG, Duleba AJ. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem. Cell Biol. 127:581-589, 2007.

Codner E, Eyzaguirre F, Iñiguez G, López P, Perez-Bravo F, Torrealba I, Cassorla F; For the Chilean Group for the Study of Ovarian Function in Type 1 Diabetes. Ovulation rate in adolescents with type 1 diabetes mellitus. Fertility and sterility. Vol. 95, Issue 1, pp. 197-202, 2011.

Amaral S, Oliveira PJ, Ramalho-Santos J. Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species. Current Diabetes Reviews 4: 46-54,2008.

Agarwal A, Gupta S, Sharma R. Oxidative stress and its implications in female infertility, a clinician's perspective. Reprod. Biomed. Online 11: 641-50, 2005.

Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol. 14: 3-28, 2005.

Wilcox AJ, Weinberg CR, Baird DD. Postovulatory ageing of the human oocyte and embryo failure. Hum. Reprod. 13: 394-397, 1998.

Nishimi A, Matsukawa T, Hoshino K, et al. Localization of nitric oxide synthase activity in unfertilized oocytes and fertilized embryos during pre-implantation development in mice. Reproduction 122: 957-963, 2001.

Khorram O. Nitric oxide and its role in blastocyst implantation. Rev. Endocr. Metab. Disord. 3: 145-149, 2002.

Merino P, Schulin-Zeuthen C, Codner E. Diagnóstico del síndrome de ovario poliquístico: nuevos fenotipos, nuevas incógnitas. Rev. Med. Chile 137: 1071-1080, 2009.

Peppard H, Marfori J, Nestler J et al. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care 24:1050-1052, 2001.

Legro R, Kunselman A, William C et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 84 (1): 165-169, 1999.

High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 2000 Nov; 85(11):4182-7.

Clinical Review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab., april 2007, 92(4):1209-1216.

Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. Bio. Med. Central Medicine, 8:41, 2010.

Morin-Papunen L et al. JCEM 2012; 97:1492-1500.

Hum. Reprod. Update 2005; 11 (4): 375-390.

Arturo Vivas, C. Síndrome de ovario poliquístico, endometrio y riesgo de aborto. Revista Colombiana de Obstetricia y Ginecología, 5(4): 303-309, 2005.

Ropelato M. Alteraciones neuroendocrinas del síndrome de poliquistosis ovárica en la adolescencia. Revista Argentina de Endocrinología y Metabolismo, 45 (2): 89-110, 2008.

PCOS Australian Alliance 2011. A single voice for polycystic ovary syndrome. Evidence based guideline for the assessment and management of PCOS www.jeanhailes.org.au.

López J. 2004. Genética en la obesidad. Rev. de Endocrinología y Nutrición. Vol. 12, Nº 4, Supl. 3.

Metwally M, Li TC, Ledger WL. The impact of obesity on female reproductive function. Obes. Rev. 2007; 8:515-23.

Ramsay JE, Greer I, Sattar N. ABC of obesity. Obesity and reproduction. BMJ 2006; 333:1159-62.

Henry Bohler et al. Fertility and sterility, Vol. 94, Nº3, august 2010.

Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, et al. The metabolic syndrome. Endocr. Rev. 2008; 29:777-822.

Ayala Yáñez R, Ayala AR. Adiposidad, inflamación e infertilidad. Revista Mexicana de Medicina de la Reproducción, Vol. 2, Nº 2: 57-62, 2009.

Santillana Espinosa E, Avila Esquivel F. Infertilidad e insulinorresistencia, Investigación materno infantil. Vol. I, Nº 3, pp. 118-122, septiembre- diciembre 2009.

Pagotto U. Where does insulin resistance start? The brain. Diabetes Care, Vol. 32, Supplement 2, November 2009.

Geisthovel F, Jochmann N, Widjaja A, Horn R, Brabant G. Serum pattern of circulating free leptin, bound leptin, and soluble leptin receptor in the physiological menstrual cycle. Fertil Steril 2004; 81:398-402.

Cervero A, Horcajadas JA, Mart J, Pellicer A, Simon C. The leptin system during human endometrial receptivity and preimplantation development. J. Clin. Endocrinol. Metab. 2004; 89:2442–51.

Zachary T Bloomgarden. Gut and adipocyte peptides. Diabetes Care, Vol. 29, Nº 2, February 2006.

Nizard Jacky et al. Pregnancy in a woman with a leptin-receptor mutation. August 30, 2012, NEJM, 366;11, 1064-1065.

Pasquali Renato et al. Obesity, fat distribution and infertility. Maturitas 2006; 54:363-371.

Davelene I, Streamson Chua Jr. Leptin receptor modulation of adiposity and fertility, Endocrinol. Metab. 2011 January; 21

Mitchell M, Armstrong DT, Robker RL, Norman RJ. Adipokines: implications for female fertility and obesity. Reproduction 2005;130: 583-97.

Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2007;10:142-8.

Bucholz H. J Clin. Endocrinol. Metab. 1999; 84:1470-4.

The Practice Committee of the American Society for Reproductive Medicine, Obesity and Reproduction: an educational bulletin. Vol. 90, Suppl. 3, November 2008.

Livshits A, Seidman DS. Fertility issues in women with diabetes. Women's Health; 5(6):701-707, 2009.

Adcock CJ, Perry LA, Lindsell DR, Taylor AM, Holly JM, Jones J, Dunger DB. Menstrual irregularities are more common in adolescents with type 1 diabetes: association with poor glycaemic control and weight gain. Diabetes Med.; 11:465-470, 1994.

Goswami R, Marwaha RK, Goswami D et al. Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J. Clin. Endocrinol. Metab.; 91(11), 4256-4259, 2006.

Enzlin P, Mathieu C, Van den Bruel A et al. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care; 25(4), 672-677, 2002.

Dorman JS, Steenkiste AR, Foley TP et al. Menopause in type 1 diabetic women, is it premature? Diabetes 50, 1857-1862, 2001.

Homan G, Davies, M, et al. The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review. Human Reproduction Update 13: 209-223, 2007.

Augood C, Duckitt K, et al. Smoking and female infertility: a systematic review and meta-analysis. Human Reproduction 13: 1532-1539, 1998.

Bolumar F, Olsen J. Smoking reduces fecundity: a european multicenter study on infertility and subfecundity. Am. J. Epidemiol. 143: 578- 587, 1996.

Agarwal A, Aponte-Mellado A, et al. The effect of oxidative stress on female reproduction: a review reproductive biology and endocrinology 2012, 10:49http://www.rbej.com/content/10/1/49.

Tiboni GM, Bucciarelli T, et al. Influence of cigarette smoking on vitamin E, vitamin A, beta-carotene and lycopene concentrations in human pre-ovulatory follicular fluid. Int. J. Immunopathol. Pharmacol. 17:389-393, 2004.

Benedict M, Missmer S, et al. Secondhand tobacco smoke exposure is associated with increase risk ok failed implantation and reduced IVF success. Human. Reproduction, 26: 2525-2531, 2011.

Howe, G Westhoff C, et al. Effects ok age, cigarette smoking and other factors on fertility: findings in a large prospective study. BMJ 290: 1697, 1985.

Tolstrup JS, Kjaer SK, Holst C, et al. Alcohol use as predictor for infertility in a representative population of danish women. Acta Obstet. Gynecol. Scand. 82:744-749, 2003.

Hakim R, Gray R, et al. Alcohol and caffeine consumption and decreased fertility. Fertil Steril 70: 632–637, 1998.

Kumar S. Occupational, environmental and lifestyle factors associated with spontaneous abortion. Reprod. Sci. 18:915-930, 2011.

Cicero AF, Tartagni E, Ertek S. Metformin and its clinical use: new insights for an old drug in clinical practice. Free Arch. Med. Sci. 2012 Nov 9; 8(5):907-17

Motta DA. Metformin in the treatment of polycystic ovary syndrome. Curr. Pharm. Res. 2008; 14: 2121-5.

Xiao J, Chen S, Zhang C, Chang S. The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis. Gynecol. Endocrinol. 2012 Dec; 28(12):956-60.

Tomova A, Deepinder F, Robeva R, Kirilov G, Mechandjiev Z, Kumanov P. Anti-müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin. Horm. Metab. Res. 2011 Sep; 43(10):723-7.

Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Cochrane Database Syst. Rev. 2012 May.

Sinawat S, Buppasiri P, Lumbiganon P, Pattanittum P. Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS. Cochrane Database Syst. Rev. 2012 Oct 17;10.

Teede H, Misso M, Deeks A, et al. 2011. MJA 195 (6) S 65-112.

Palomba S, Falbo A. La Sala GB BJOG. 2013 Feb; 120(3):267-76.

Xiao J, Chen S, Zhang C, Chang S. Gynecol. Endocrinol. 2012 Dec; 28(12):956-60.

Palomba S, Falbo A, Orio F. Fertility and sterility. 2009; 92(5):1646-1658.

Duranteau L, Lefevre P, Jeandidier N, Simon T, Christin-Maitre S. Should physicians prescribe metformin towomen with polycystic ovary syndrome (PCOS)? Ann. Endocrinol. 2010; 71: 25-7.

Rouzi AA, Ardawi MS. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2006 Feb; 85(2):428-35.

Minge CE, Robker RL, Norman RJ. PPAR Gamma: coordinating metabolic and immune contributions to female fertility. PPAR Res. 2008:243791.

Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst. Rev. 2012, May 16; 5:CD003053.

Fromentand P, Touraine P. Thiazolidinediones and fertility in polycystic ovary syndrome (PCOS). PPAR Research, Vol. 2006, article ID 73986,1-8.

Elhadd T, Fiad T, Meer L. Ovarian stockpiling in polycystic ovary syndrome, infertility, and the combined use of rosiglitazone and metformin. Diabetes Care, 2006. 29: 2330-2331.

Ota H, Goto T, Yoshioka T, Ohyama N. Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome. Fertil Steril. 2008 Sep; 90(3):709-13.

Kircher C, Smith KP. Acarbose for polycystic ovary syndrome. Ann Pharmacother. 2008 Jun; 42(6):847-51.

Ciotta L, Calogero A, Farina M, De Leo V, La Marca A, Cianci A. Clinical, endocrine and metabolic effects of acarbose, and a-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance. Hum. Reprod. 2001; 16:2066-72.

Penna IAA, Canella PRB, Reis RM, Silva de Sá MF, Ferriani RA. Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study. Hum Reprod 2005;20:2396-401.

Tuğrul S, Kutlu T, Pekin O, Bağlam E, Kiyak H, Oral O. Clinical, endocrine, and metabolic effects of acarbose, a alpha-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome. Fertil Steril. 2008 Oct; 90(4):1144-8.

Sönmez AS, Yasar L, Savan K, et al. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate–resistant polycystic ovary syndrome. Hum. Reprod. 2004; 20:175-9.

Gaal Z, Klupa T, Kantor I, Mlynarski W, Albert L, Tolloczko J, Balogh I, Czajkowski K, Malecki MT. Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases. Diabetes Care. 2012 Jun; 35(6):e40.

Klupa T, Kozek E, Nowak N et al. The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancy. J. Clin. Endocrinol. Metab. 2010 Aug; 95(8):3599-604.

Tieu J, Coat S, et al. Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 7, Art. Nº CD007724.

Strauss TJ, Castrillon DH, Hammes SR. GATA-like protein-1 (GLP-1) is required for normal germ cell development during embryonic oogenesis. Reproduction. 2011 Feb; 141(2):173-81.

Rüter J, Hoffmann T, Heiser U, Demuth HU, Arck PC, Klapp BF, Hildebrandt M. The expression of T-cell surface antigens CTLA-4, CD26, and CD28 is modulated by inhibition of dipeptidylpeptidase IV (DPP IV, CD26) activity in murine stress-induced abortions. Cell Immunol. 2002 Dec; 220(2):150-6.

Nishikawa M, Itakura A, Ito M, Takeuchi M, Sato Y, Kajiyama H, Mizutani S, Kikkawa F. Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction. Horm. Metab. Res. 2005 Jul;37(7):408-13.




DOI: http://dx.doi.org/10.47196/diab.v48i2.185

Copyright (c) 2020 Sociedad Argentina de Diabetes Asociación Civil

ADVERTISEMENT
ADVERTISEMENT